University of California San Francisco, San Francisco, California, USA.
Am J Med Genet A. 2010 Jan;152A(1):4-24. doi: 10.1002/ajmg.a.33183.
The RASopathies are a group of genetic syndromes caused by germline mutations in genes that encode components of the Ras/mitogen-activated protein kinase (MAPK) pathway. Some of these syndromes are neurofibromatosis type 1, Noonan syndrome, Costello syndrome, cardio-facio-cutaneous syndrome, LEOPARD syndrome and Legius syndrome. Their common underlying pathogenetic mechanism brings about significant overlap in phenotypic features and includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, GI and ocular abnormalities, and a predisposition to cancer. The proceedings from the symposium "Genetic Syndromes of the Ras/MAPK Pathway: From Bedside to Bench and Back" chronicle the timely and typical research symposium which brought together clinicians, basic scientists, physician-scientists, advocate leaders, trainees, students and individuals with Ras syndromes and their families. The goals, to discuss basic science and clinical issues, to set forth a solid framework for future research, to direct translational applications towards therapy and to set forth best practices for individuals with RASopathies were successfully meet with a commitment to begin to move towards clinical trials.
RAS 相关疾病是一组由 Ras/丝裂原活化蛋白激酶(MAPK)通路相关基因的胚系突变引起的遗传综合征。这些综合征包括神经纤维瘤病 1 型、Noonan 综合征、Costello 综合征、心面四肢综合征、LEOPARD 综合征和 Legius 综合征。它们共同的潜在发病机制导致了表型特征的显著重叠,包括颅面畸形、心脏、皮肤、肌肉骨骼、胃肠道和眼部异常,以及癌症易感性。本次研讨会的会议记录“Ras/MAPK 通路的遗传综合征:从床边到实验室再到临床”,记录了一次及时而典型的研究研讨会,汇集了临床医生、基础科学家、医师科学家、倡导领袖、受训者、学生和 Ras 综合征患者及其家属。会议的目标是讨论基础科学和临床问题,为未来的研究奠定坚实的框架,将转化应用指向治疗,并为 RAS 相关疾病患者制定最佳实践。会议成功地达到了这些目标,并承诺开始进行临床试验。